The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease

scientific article published on 01 July 1999

The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0264-410X(99)00114-0
P698PubMed publication ID10471189

P2093author name stringK L Nichol
P2860cites workReduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in SpainQ33704652
Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.Q34714546
Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice databaseQ36504369
Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trialsQ40650875
Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderlyQ40673114
Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderlyQ43418868
Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organizationQ45260225
The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.Q50602332
Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasonsQ57109900
Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981Q69262720
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizensQ77302768
P921main subjectlung diseaseQ3392853
P304page(s)S91-3
P577publication date1999-07-01
P1433published inVaccineQ7907941
P1476titleThe additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease
P478volume17 Suppl 1

Reverse relations

cites work (P2860)
Q50462536Accuracy of diagnosis and classification of COPD in primary and specialist nurse-led respiratory care in Rotherham, UK: a cross-sectional study.
Q57954001Additional, not additive
Q39014333Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease
Q57102084Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers
Q37561339Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis
Q37625249Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly.
Q53326961Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands.
Q30309620Current research on respiratory viral infections: Fourth International Symposium
Q37167208Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease?
Q36665557Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity
Q40079245Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study
Q33719116Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies
Q30429085Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
Q73816676Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up
Q33257893Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up
Q37135413Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study
Q47750958Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-infe
Q43177604Influenza and pneumococcal vaccination of the elderly in Taiwan
Q30350930Influenza vaccination in the elderly: impact on hospitalisation and mortality.
Q80394362Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers
Q83914964Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease
Q34926870Pneumococcal Vaccination and Revaccination of Older Adults
Q50580026Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia.
Q50672508Pneumococcal infection and vaccination in the elderly.
Q47162758Pneumococcal vaccination and chronic respiratory diseases
Q56524976Predictors of yearly influenza vaccination in hospitalized and community based patients
Q28596774Prevention of COPD exacerbations: medications and other controversies
Q91743322Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study
Q35021125Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization
Q93645697Reference list
Q40982885The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
Q35857208The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials
Q21261529The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004
Q90435619Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017
Q24201474Vaccines for preventing pneumococcal infection in adults
Q24242290Vaccines for preventing pneumococcal infection in adults
Q24247752Vaccines for preventing pneumococcal infection in adults

Search more.